MedPath

Zydus Pharmaceuticals (USA) Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

304

FDA:304

Drug Approvals

Maraviroc

Approval Date
May 15, 2025
FDA

Hydralazine Hydrochloride

Approval Date
Mar 27, 2025
FDA

Miglustat

Approval Date
Mar 17, 2025
FDA

Topiramate

Approval Date
Apr 2, 2024
FDA

fesoterodine fumarate

Approval Date
Apr 2, 2024
FDA

balsalazide disodium

Approval Date
Mar 29, 2024
FDA

Divalproex Sodium

Approval Date
Mar 28, 2024
FDA

divalproex sodium

Approval Date
Mar 27, 2024
FDA

Nortriptyline Hydrochloride

Approval Date
Mar 27, 2024
FDA

Ursodiol

Approval Date
Mar 26, 2024
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 31
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.